Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities - PubMed (original) (raw)
Review
Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities
Nadezda Vashchenko et al. Eur Urol. 2005 Feb.
Abstract
Objectives: This review aims to provide practising clinicians with the most recent knowledge of the biological nature of prostate cancer (PC) to facilitate investigation of new treatment modalities for patients with PC, especially the hormone-refractory state of the disease.
Methods: Review of the literature using PubMed search and scientific journal publications.
Results: Much progress has been made towards an understanding of the development and progression of PC, and the factors which drive the development of androgen independence. Neuroendocrine (NE) cells may provide an intriguing link between NE cell differentiation and tumour progression in PC with the genetically supported formation of androgen-independent clones which regulate the proliferation of neighbouring non-NE-phenotype cancer cells in a paracrine manner by secretion of NE products. Various NE peptides stimulate proliferation of androgen-independent PC through transactivation of the androgen receptors (AR). Therefore, cancerous epithelial cells that increase their responsiveness to NE factors or induce NE cells to release trophic factors may have a survival advantage over their siblings.
Conclusion: This review shows the need to improve our understanding of the biological nature of PC, especially cancer cells of the NE phenotype and their regulatory products to develop new therapeutic protocols and trials based on NE hormones and their agonists/antagonists.
Similar articles
- Neuroendocrine differentiation in prostate cancer: from lab to bedside.
Cindolo L, Cantile M, Vacherot F, Terry S, de la Taille A. Cindolo L, et al. Urol Int. 2007;79(4):287-96. doi: 10.1159/000109711. Urol Int. 2007. PMID: 18025844 Review. - Androgen deprivation of the PC-310 [correction of prohormone convertase-310] human prostate cancer model system induces neuroendocrine differentiation.
Jongsma J, Oomen MH, Noordzij MA, Van Weerden WM, Martens GJ, van der Kwast TH, Schröder FH, van Steenbrugge GJ. Jongsma J, et al. Cancer Res. 2000 Feb 1;60(3):741-8. Cancer Res. 2000. PMID: 10676662 - The neuroendocrine phenotype in prostate cancer: basic and clinical aspects.
Mosca A, Berruti A, Russo L, Torta M, Dogliotti L. Mosca A, et al. J Endocrinol Invest. 2005;28(11 Suppl International):141-5. J Endocrinol Invest. 2005. PMID: 16625864 Review. - Adrenomedullin, an autocrine/paracrine factor induced by androgen withdrawal, stimulates 'neuroendocrine phenotype' in LNCaP prostate tumor cells.
Berenguer C, Boudouresque F, Dussert C, Daniel L, Muracciole X, Grino M, Rossi D, Mabrouk K, Figarella-Branger D, Martin PM, Ouafik L. Berenguer C, et al. Oncogene. 2008 Jan 17;27(4):506-18. doi: 10.1038/sj.onc.1210656. Epub 2007 Jul 16. Oncogene. 2008. PMID: 17637748
Cited by
- Overexpression of REST Represses the Epithelial-Mesenchymal Transition Process and Decreases the Aggressiveness of Prostate Cancer Cells.
Indo S, Orellana-Serradell O, Torres MJ, Castellón EA, Contreras HR. Indo S, et al. Int J Mol Sci. 2024 Mar 15;25(6):3332. doi: 10.3390/ijms25063332. Int J Mol Sci. 2024. PMID: 38542313 Free PMC article. - Single-cell sequencing revealed metabolic reprogramming and its transcription factor regulatory network in prostate cancer.
Wei G, Zhu H, Zhou Y, Pan Y, Yi B, Bai Y. Wei G, et al. Transl Oncol. 2024 Jun;44:101925. doi: 10.1016/j.tranon.2024.101925. Epub 2024 Mar 6. Transl Oncol. 2024. PMID: 38447277 Free PMC article. - PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review.
Dondi F, Antonelli A, Suardi N, Guerini AE, Albano D, Lucchini S, Camoni L, Treglia G, Bertagna F. Dondi F, et al. Cancers (Basel). 2023 Sep 3;15(17):4404. doi: 10.3390/cancers15174404. Cancers (Basel). 2023. PMID: 37686680 Free PMC article. Review. - In vivo prostate cancer research: Key interspecies prostate anatomical features for translation medicine.
Nascimento-Gonçalves E, Seixas F, Ferreira R, Oliveira PA, Colaço B. Nascimento-Gonçalves E, et al. Open Vet J. 2023 Jun;13(6):782-793. doi: 10.5455/OVJ.2023.v13.i6.13. Epub 2023 Jun 21. Open Vet J. 2023. PMID: 37545707 Free PMC article. Review. - Transformable Neuropeptide Prodrug with Tumor Microenvironment Responsiveness for Tumor Growth and Metastasis Inhibition of Triple-Negative Breast Cancer.
Cao Y, Ge X, Zhu X, Han Y, Wang P, Akakuru OU, Wu A, Li J. Cao Y, et al. Adv Sci (Weinh). 2023 Jul;10(21):e2300545. doi: 10.1002/advs.202300545. Epub 2023 May 5. Adv Sci (Weinh). 2023. PMID: 37147783 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials